Home › NCT05440760
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
Recruiting
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Female, ≥ 18 years of age * Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy * Able to provide written consent Exclusion Criteria: * Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound * History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras * Known history of elevated intraocular pressure * Claustrophobia, thalassophobia, cleithrophobia or similar phobias * Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen
About the study
The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow.
The secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural/acute pain, and need for analgesics or anxiolytics.
What is being tested
- The Oculus Quest 2 Virtual Reality Headset (device)
Sponsor: University of Arkansas · Participants: 20 · Started: Aug 8, 2022
Contact the study team
- Joseph A Holley · Phone: 501-686-8274
- Vernon Sincere · Phone: 501-686-8274
Official record on ClinicalTrials.gov — NCT05440760
Locations in the U.S.
| Arkansas | University of Arkansas for Medical Sciences, Little Rock |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.